At the moment there are three main challenges in idiopathic aplastic anemia; the place of receptor agonists, transplantations in older people and match unrelated transplantation upfront in pediatric patients. Tomorrow we will have a nice overview during the talk in the afternoon with three main speakers inlcuding Carlo Dufour, our chair, who will discuss upfront match unrelated transplantations in kids which is risky but can quickly cure these patients and US speaker Danielle Townsley who will speak largely about eltrombopag and how we can improve the response for patients who are not eligible for transplants...
At the moment there are three main challenges in idiopathic aplastic anemia; the place of receptor agonists, transplantations in older people and match unrelated transplantation upfront in pediatric patients. Tomorrow we will have a nice overview during the talk in the afternoon with three main speakers inlcuding Carlo Dufour, our chair, who will discuss upfront match unrelated transplantations in kids which is risky but can quickly cure these patients and US speaker Danielle Townsley who will speak largely about eltrombopag and how we can improve the response for patients who are not eligible for transplants. Finally, we have a speaker coming from King’s, UK, Dr. Potter, who will speak about transplantation in older age and will show some nice data suggesting that transplantation is going further and further and is something that is possible for the people.
